InspireMD announces FDA approval of CGuard Prime stent system for TCAR procedures
NSPR•InspireMD announced FDA approval of its CGuard Prime transcarotid stent system for TCAR procedures, saying approval doubles its U.S. market with access to 35,000 procedures annually.
1. FDA approval
InspireMD announced FDA approval of the CGuard Prime transcarotid stent system for transcarotid artery revascularization procedures. The company said approval doubles CGuard Prime’s U.S. market, providing access to 35,000 TCAR procedures annually.
